SLC7A11 and adrenal cortex carcinoma: We found that high expression of SLC7A11, GPX4, and AIFM2 were significantly linked with the shortened disease-free survival in adrenocortical carcinoma (ACC), respectively, and high expression of SLC7A11 and AIFM2 were significantly associated with shortened OS in ACC respectively (Figures 3A–I).